Avtal | $24,000,000 | (Mar 20, 2026)
games2gether | $5,202,945 | (Mar 20, 2026)
Claros | $30,000,000 | (Mar 20, 2026)
Vynca
United States
- Palo Alto, CA
- 31/01/2022
- Series C
- $30,000,000
Vynca enables high-quality, person-centered, goal-concordant care that reflects individuals’ wishes with their serious illness management platform that incorporates virtual palliative care services, advance care planning, care coordination, symptom management, whole-person care and provider engagement. The company’s comprehensive solution set empowers providers, individuals and their families to have meaningful conversations about future care preferences supported by a broad range of serious illness management services offered from a single point of trust to deliver successful value-based arrangements to healthcare organizations. With this approach, Vynca is able to ensure that personalized end-of-life care is available for every individual, every time.
- Industry Hospital & Health Care
- Website https://vyncahealth.com/
- LinkedIn https://www.linkedin.com/company/vynca/
Latent | $80,000,000 | (Mar 20, 2026)
Corridor | $25,000,000 | (Mar 20, 2026)
RunSybil | $40,000,000 | (Mar 20, 2026)
Ezra AI Labs | $3,200,000 | (Mar 20, 2026)
Parallel(FRANCE) | $20,000,000 | (Mar 20, 2026)
Health Universe | $6,000,000 | (Mar 20, 2026)
PADO AI | $6,000,000 | (Mar 20, 2026)
Edra | $30,000,000 | (Mar 20, 2026)
Chalkie AI | $4,000,000 | (Mar 20, 2026)
Deeptune | $43,000,000 | (Mar 20, 2026)